Synergistic Effect of Anethole and Platinum Drug Cisplatin against Oral Cancer Cell Growth and Migration by Inhibiting MAPKase, Beta-Catenin, and NF-κB Pathways

Cisplatin is a common drug used to treat patients with oral squamous cell carcinoma. However, cisplatin-induced chemoresistance poses a major challenge to its clinical application. Our recent study has shown that anethole possesses an anti-oral cancer effect. In this study, we examined the combined...

Descripción completa

Detalles Bibliográficos
Autores principales: Semlali, Abdelhabib, Ajala, Ikram, Beji, Sarra, Al-Zharani, Mohammed Mousa, Rouabhia, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221564/
https://www.ncbi.nlm.nih.gov/pubmed/37242484
http://dx.doi.org/10.3390/ph16050700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221564/
https://www.ncbi.nlm.nih.gov/pubmed/37242484
http://dx.doi.org/10.3390/ph16050700

Ejemplares similares